1. Afolabi BB, Oyeneyin OL, Ogedengbe OK. Intravaginal misoprostol versus Foley catheter for cervical ripening and induction of labor. International Journal of Gynecology & Obstetrics. 2005 Jun;89(3):263-7. [
DOI:10.1016/j.ijgo.2005.02.010] [
PMID]
2. Berkowitz RS, Goldstein DP. Gestational trophoblastic disease. Cancer. 1995 Nov 15;76(S10):2079-85.
https://doi.org/10.1002/1097-0142(19951115)76:10+<2079::AID-CNCR2820761329>3.0.CO;2-O [
DOI:10.1002/1097-0142(19951115)76:10+3.0.CO;2-O]
3. Wing DA, Gaffaney CA. Vaginal misoprostol administration for cervical ripening and labor induction. Clin Obstet Gynecol. 2006 Sep; 49(3):627-41. [DOI:10.1097/00003081-200609000-00021] [PMID] [
DOI:10.1097/00003081-200609000-00021] [
PMID]
4. Gelber S, Sciscione A. Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol. ٢٠٠٦ Sep; 49(3):642-57. [DOI:10.1097/00003081-200609000-00022] [PMID] [
DOI:10.1097/00003081-200609000-00022] [
PMID]
5. Shepherd JH, Knuppel RA.The role of prostaglandins in ripening the cervix and inducing labor. Clin Perinatol. 1981 Feb; 8(1):49-62. [DOI:10.1016/S0095-5108(18)31094-7] [
DOI:10.1016/S0095-5108(18)31094-7]
6. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Sys Rev. 2003;(1):CD000941. [DOI:10.1002/14651858.CD000941] [PMCID] [
DOI:10.1002/14651858.CD000941] [
PMCID]
7. Ghosh A1, Lattey KR2, Kelly AJ1. Nitric oxide donors for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2016 Dec 5;12:CD006901. [
DOI:10.1002/14651858.CD006901.pub3] [
PMID] [
PMCID]
8. Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth's obstetrics and gynecology. Philadelphia, PA: Lippincott Williams & Wilkins; 2008 Apr 23
9. Keirse MJ. Termination of molar pregnancy by intramuscular administration of ١٥(S)-١٥-methyl-prostaglandin F٢ alpha. Prostaglandins Med. 1980 May;4(5): 333-9. [DOI:10.1016/0161-4630(80)90007-5] [
DOI:10.1016/0161-4630(80)90007-5]
10. Fischer Z, Chwalisz K, Michałkiewicz W. Termination of normal and pathologicalpregnancy with Sulprostone. Acta Chir Hung. 1986;27(3):151- 6.
11. Chow PK. Partial Hydatidiform Mole in a Medical Abortion with the Mifepristone/ Misoprostol Combination.Taiwanese Journal of Obstetrics and Gynecology 2004; 43 (4): 233-234 [
DOI:10.1016/S1028-4559(09)60094-2]
12. 12- T. Y. Ng, lc wong diagnosis and management of gestational trophoblasticneo plasia ,Best practice& research. clinical obstetrics & Gynecology, Nov 2003, 17(6): 893-903. [DOI:10.1016/S1028-4559(09)60094-2] [
DOI:10.1016/S1028-4559(09)60094-2]
13. James S, Epidimiology of gestational trophoblastic diseases, Best practice & Research. Clinical obstetrics & Gynecology, February (2004), 18(1): A2 - A9.
14. Bugti Q, Baloch N, Baloch M, gestational trophoblastic diseases in Quetta, Pakistan J. Med. Res, 2005،44 (2): 92-
15. Altman AD, BentleyB, MurrayS, et al, Maternal age related rates of gestationatrophoblastic disease, obstet gynecol, 2008, 112(2pt1): 224-50. 83 [DOI:10.1097/AOG.0b013e3181802186] [PMID] [
DOI:10.1097/AOG.0b013e3181802186] [
PMID]
16. Altier A, Franceschi s, Ferlay j, Epidemiology and aetiology of gestational trophoblastic disease, the lancet oncology,nov 2003, 4(11): 670- 678. [DOI:10.1016/S1470-2045(03)01245-2] [
DOI:10.1016/S1470-2045(03)01245-2]
17. Gemzell-Danielsson KC, Fiala C, Weeks A. Misoprostol: first-line therapy for incomplete miscarriage in the developing world. BJOG 2007;114:1337-9. [DOI:10.1111/j.1471-0528.2007.01491.x] [PMID] [
DOI:10.1111/j.1471-0528.2007.01491.x] [
PMID]
18. Phupong V, Taneepanichskul S, Kriengsinyot R, Sriyirojana N, Blanchard K, Winikoff B. Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion. Contraception 2004;70:307-11 [DOI:10.1016/j.contraception.2004.04.002] [PMID] [
DOI:10.1016/j.contraception.2004.04.002] [
PMID]
19. Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynaecol Obstet 2007;99 (Suppl 2):S186-9. [DOI:10.1016/j.ijgo.2007.09.009] [PMID] [
DOI:10.1016/j.ijgo.2007.09.009] [
PMID]
20. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002;186:470-4. [DOI:10.1067/mob.2002.121085] [PMID] [
DOI:10.1067/mob.2002.121085] [
PMID]
21. Noor N, Ansari M, Ali SM, Parveen S. Foley catheter versus vaginal misoprostol for labour induction. International journal of reproductive medicine. 2015;2015. [DOI:10.1155/2015/845735] [PMID] [PMCID] [
DOI:10.1155/2015/845735] [
PMID] [
PMCID]
22. Jozwiak M, ten Eikelder M, Oude RK, de Groot C, Feitsma H, Spaanderman M, van Pampus M, de Leeuw JW, Mol BW, Bloemenkamp K. Foley catheter versus vaginal misoprostol: randomized controlled trial (PROBAAT-M study) and systematic review and meta-analysis of literature. American journal of perinatology. 2014 Feb;31(2):145-56. [DOI:10.1055/s-0033-1341573] [PMID] [
DOI:10.1055/s-0033-1341573] [
PMID]
23. Chen W, Xue J, Gaudet L, Walker M, Wen SW. Meta-analysis of Foley catheter plus misoprostol versus misoprostol alone for cervical ripening. International Journal of Gynecology & Obstetrics. 2015 Jun 30;129(3):193-8. [DOI:10.1016/j.ijgo.2015.01.005] [PMID] [
DOI:10.1016/j.ijgo.2015.01.005] [
PMID]